Subscribe to our Newsletters !!
Few developments in science and technology have be
In modern pharmaceutical and laboratory settings,
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceuticals Limited (Alembic) today an
2026 marks a new chapter for the pharmaceutical an
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-lo
BioNTech’s co-founder and chief executive said that he was hopeful that the protective effect of its experimental COVID-19 vaccine, co-developed with Pfizer, would endure for at least a year. Both companies earlier on Monday became the primary drugmakers to launch successful trial statistics, stating their vaccine was demonstrated to be 90 percent successful, a major success in the fight against the pandemic. While it was not yet known how long the protection could last, study on recovered sufferers and earlier findings in their vaccine led him to believe protection wouldn’t be short-lived.
